Home LiteratureArticle Details
PMID: 56646 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs.

Lancet (London, England) ·Vol. 1 ·No. 7964 ·1976-04-17 ·Pages 821-5

Starzl TE, Watanabe K, Porter KA, Putnam CW

Abstract

Insulin, glucagon, and insulin/glucagon mixtures have been infused for four days into the left portal vein of dogs after portacaval shunt. In the left but not in the right liver lobes, insulin alone reduced atrophy, preserved hepatocyte ultrastructure, and trebled cell renewal. Glucagon alone had no effect. In small doses, glucagon did not potentiate the action of insulin and in large doses it may have reduced the insulin benefit. These studies explain the development of the previously mysterious Eck fistula syndrome, provide clues about in-vivo cell growth control by hormones, and suggests new lines of inquiry about the pathogenesis and/or treatment of several human disease processes.

MeSH Terms
Animals Atrophy Blood Glucose/analysis Dogs Glucagon/administration & dosage,pharmacology Infusions, Parenteral Insulin/administration & dosage,deficiency,pharmacology Liver/cytology,pathology Liver Diseases/etiology,pathology,prevention & control Liver Regeneration/drug effects Portacaval Shunt, Surgical/adverse effects Portal Vein
Chemicals
Blood Glucose Insulin Glucagon
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Starzl T E
Watanabe K
Porter K A
Putnam C W
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
1976-04-17
Pages
821-5
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com